Innovative Drugs_Innovation & Research_Beijing Wista Pharma Co., Ltd_Beijing Wista Pharma Co., Ltd}

Drug Code	Therapeutic Area	R & D progress	Remark
WYL-001A	Treatment of glioma, gastric cancer, etc	Preclinical
WYL-001C	Treatment of diffuse large B-cell lymphoma	Preclinical
WGR-002	Prevention and treatment of atherosclerosis, hyperchole	Preclinical

Drug Code

Therapeutic Area

Candidate drugs

Preclinical

Phase I

Phase II

Phase III

Registration Filing

Drug Code

R & D Progress

WYL-001A/C

Treatment of glioma, gastric cancer, etc

Drug Code

R & D Progress

WYL-001B

Treatment of diffuse large B-cell lymphoma

Drug Code

R & D Progress

WYL-002

Prevention and treatment of atherosclerosis, hyperchole

乐发500